NFATC1 and Arthritis: It also ameliorated adjuvant-induced arthritis (AIA) in mice by targeting critical mediators of arthritis development, such as receptor activator of nuclear factor-kappa B ligand (RANKL) and nuclear factor of activated T-cells, cytoplasmic 1 (NFATc1) (74).